151 people who came into contact with the victim are under observation to prevent the spread of the deadly virus
world14 hours ago
Guardant Health said its blood test to detect a cancer that starts in the colon or rectum got an approval from the US Food and Drug Administration, sending the company's shares up 16 per cent in premarket trading on Monday.
The test, known as Shield, has been available in the US as a laboratory-developed test (LDT) since 2022 and is available for a self-pay price of $895.
LDTs are designed, manufactured and used within a single laboratory, but FDA's approval takes Shield a step closer to becoming the first blood test for colorectal cancer (CRC) screening that is eligible for Medicare insurance coverage for older adults.
Guardant did not provide the self-pay price of the FDA-approved version of the test. If covered under certain Medicare plans for people aged 65 and older, patients usually do not have to bear out-of-pocket cost for such tests.
Advisers to the FDA voted to approve the blood test in May, with the regulator allowing its use for adults aged 45 years and older.
Blood-based tests are more convenient than feces-based tests, such as Exact Sciences' Cologuard, for cancer screening.
The FDA decision helps Shield test target more than 50 million people who remain unscreened, Leerink Partners analyst Puneet Souda said.
Shield's approval is the second for a blood-based test for CRC screening in the United States after Epigenomics' Epi proColon, which was approved in 2016 but failed to meet the government's 74 per cent or more sensitivity criteria for Medicare coverage.
According to the FDA's documents, a study showed Guardant's Shield test detected 83 per cent of colorectal cancers. Exact Sciences' stool test Cologuard had a 92.3 per cent sensitivity rate.
Colonoscopy is considered the gold standard test for CRC.
CRC occurs in about 150,000 patients in the US annually and is the second-leading cause of cancer fatalities in the country, with more than 50,000 deaths each year, according to the FDA.
151 people who came into contact with the victim are under observation to prevent the spread of the deadly virus
world14 hours ago
Her cheeky expressions and playful frolicking racked up millions of views and have lured thousands of visitors wanting to witness her antics
world1 day ago
China issues red alert, warns of gales and heavy rain
world1 day ago
Celebrity endorsements rarely carry enormous weight, but the hugely popular Swift is seen as being in a class of her own
world1 day ago
Brazil has been parched by a historic drought that experts link to climate change and which has sparked what authorities have called a 'fire pandemic'
world1 day ago
Generative artificial intelligence uses 30 times more energy than a traditional search engine
world1 day ago
SalamAir flight from Bangladesh's Chittagong was diverted to Nagpur Airport following a medical emergency
world1 day ago
The Dragon spacecraft landed in the ocean at 3.37am, a webcast of the splashdown showed, with a recovery team deploying in the pre-dawn darkness to retrieve the capsule and crew
world1 day ago